{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:42:01Z","timestamp":1773859321139,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Pregabalin and duloxetine are widely prescribed non\u2010opioid medications for chronic musculoskeletal pain. Pregabalin may increase the risk of heart failure, and duloxetine increases heart rate and blood pressure; however, little is known about their comparative cardiovascular safety. This study compared cardiovascular outcomes between new users of pregabalin and new users of duloxetine among US Veterans with chronic musculoskeletal conditions. We conducted a retrospective cohort study of US Veterans, aged 18\u201389\u2009years, with chronic non\u2010cancer musculoskeletal pain who started pregabalin or duloxetine between 2015 and 2021. Veterans with serious illnesses were excluded. The primary outcome was a major adverse cardiovascular event (MACE), a composite of acute myocardial infarction (AMI), stroke, heart failure (HF), or cardiovascular death. We identified cardiovascular events through Veterans Affairs and linked Medicare data and mortality data from the National Death Index. We adjusted for confounding through inverse probability of treatment weighting utilizing a propensity score incorporating 158 covariates. Outcomes were analyzed using Cox proportional hazard regression models. This study included 26,684 new users of pregabalin and 152,808 new users of duloxetine (83% male, 69% reported White race, median age\u2009=\u200956\u2009years). During a total follow\u2010up of 141,112 person\u2010years, there were 1,798 total MACE events. The rate of MACE was higher for pregabalin users compared to duloxetine users (unadjusted HR: 1.61 (95% CI: 1.43\u20131.81), adjusted HR: 1.24 (95% CI: 1.08\u20131.41)), driven by higher rates of HF and AMI among pregabalin users. These findings present new considerations regarding the comparative cardiovascular safety of therapeutic options for chronic musculoskeletal pain.<\/jats:p>","DOI":"10.1002\/cpt.70215","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:01:03Z","timestamp":1770274863000},"page":"1088-1094","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal Pain"],"prefix":"10.1002","volume":"119","author":[{"given":"Sachalee","family":"Campbell","sequence":"first","affiliation":[{"name":"Department of Medicine University of Miami  Miami Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puran","family":"Nepal","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Miami  Miami Florida USA"},{"name":"Miami VA Healthcare System Research Service  Miami Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-5915","authenticated-orcid":false,"given":"Laura","family":"Daniel","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Miami  Miami Florida USA"},{"name":"Miami VA Healthcare System Research Service  Miami Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otis","family":"Wilson","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center  Nashville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3404-3802","authenticated-orcid":false,"given":"Alyson L.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center  Nashville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-3826","authenticated-orcid":false,"given":"Jennifer","family":"Maizel","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Miami  Miami Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine T.","family":"Murray","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center  Nashville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-599X","authenticated-orcid":false,"given":"William D.","family":"Dupont","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center  Nashville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Hung","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center  Nashville Tennessee USA"},{"name":"VA Tennessee Valley Healthcare System Research Service  Nashville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne A.","family":"Ray","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center  Nashville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"Stein","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center  Nashville Tennessee USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3325-2817","authenticated-orcid":false,"given":"Cecilia P.","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Miami  Miami Florida USA"},{"name":"Miami VA Healthcare System Research Service  Miami Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"e_1_2_10_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32340-0"},{"key":"e_1_2_10_2_1","unstructured":"World Health Organization.Musculoskeletal health(2022). <https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/musculoskeletal\u2010conditions>."},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.22.00693"},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","unstructured":"Lucas J.W.&Sohi I.Chronic pain and high\u2010impact chronic pain in U.S. adults 2023(2024). Hyattsville MD: U.S. Department of Health & Human Services Centers for Disease Control and Prevention National Center for Health Statistics.","DOI":"10.15620\/cdc\/169630"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.0147"},{"key":"e_1_2_10_6_1","unstructured":"U.S. Food & Drug Administration.Cymbalta(2014). <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/021427Orig1s045lbl.pdf>."},{"key":"e_1_2_10_7_1","unstructured":"U.S. Food & Drug Administration.Lyrica(2018). <https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021446s035%2C022488s013lbl.pdf>."},{"key":"e_1_2_10_8_1","volume-title":"Pregabalin","author":"Cross A.L.","year":"2025"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000287643.13410.5e"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1807061"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112807"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4239"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40138-019-00182-5"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2021.35.S1.04622"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.02.022"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730050-00007"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000155815.44338.95"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2023-eular.2795"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01610-9"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00969-6"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000001105"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247595"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12452"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307515"},{"key":"e_1_2_10_25_1","unstructured":"U.S. Department of Veterans Affairs.VA informatics and computing infrastructure (VINCI)<https:\/\/www.research.va.gov\/programs\/vinci\/>. Accessed June 20 2025."},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000244657.90074.b7"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.21383"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg231"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5407"},{"key":"e_1_2_10_30_1","unstructured":"U.S. Department of Health and Human Services.Guidance regarding methods for de\u2010identification of protected health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA) privacy rule<https:\/\/www.hhs.gov\/hipaa\/for\u2010professionals\/special\u2010topics\/de\u2010identification\/index.html>. Accessed June 20 2025."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1821"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1999.10198.x"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002862"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1518"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107214"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2313"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.122.009078"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.03.007"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000156"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3019"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5753"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3727"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3282fb7629"},{"key":"e_1_2_10_45_1","unstructured":"European Medicines Agency.Annex I\u2013Summary of Product Characteristics<https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/lyrica\u2010epar\u2010product\u2010information_en.pdf>."},{"key":"e_1_2_10_46_1","first-page":"13","article-title":"Cardiovascular effects of antidepressant drugs: updated","volume":"59","author":"Glassman A.H.","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804988"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.25803"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31924-X"},{"key":"e_1_2_10_50_1","unstructured":"United States Census Bureau.Veterans Day 2024: November 11(2024). <https:\/\/www.census.gov\/newsroom\/facts\u2010for\u2010features\/2024\/veterans\u2010day.html>."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70215","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.70215","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:43:22Z","timestamp":1773834202000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/cpt.70215"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70215","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"2025-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}